[The conservative treatment of chronic inflammatory rheumatism].
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002648:Child; D002908:Chronic Disease; D005260:Female; D005439:Flufenamic Acid / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007223:Infant; D008134:Long-Term Care; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use; D008875:Middle Aged; D009132:Muscles / Q000627:therapeutic use; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D011241:Prednisone / Q000627:therapeutic use; D012046:Rehabilitation; D012459:Salicylates / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D007166:Immunosuppressive Agents; D012459:Salicylates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D006046:Gold; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D011241:Prednisone; D007213:Indomethacin
Traitement conservateur des rhumatismues inflammatories chroniques.